References
- Vigen R, O’Donnell CI, Baron AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA 2013;310:1829–36
- Finkle WD, Greenland S, Ridgeway GK, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One 2014;9:e85805
- New York Times Editorial Board. Overselling testosterone, dangerously. Available from: http://www.nytimes.com/2014/02/05/opinion/overselling-testosterone-dangerously.html?_r=0. Published online 4 Feb 2014
- Fisher ES, Whaley FS, Krushat WM, et al. The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health. 1992;82:243–8
- Correction: incorrect Language. JAMA 2014;311:306
- Morgentaler A, Traish A, Kacker R. Re: deaths and cardiovascular events in men receiving testosterone. JAMA 2014;311:961–2
- Ho PM, Barón AE, Wierman ME. Deaths and cardiovascular events in men receiving testosterone-reply. JAMA 2014;311:964–5
- Correction: incorrect number of excluded patients reported in the text and figure. JAMA 2014;311:967
- Traish AM, Guay AT, Morgentaler A. Death by testosterone? We think not! J Sex Med 2014;11:624–9
- Shores MM, Smith NL, Forsberg CW, et al. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab. 2012;97:2050–8
- Muraleedharan V, Marsh H, Kapoor D, et al. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes. Eur J Endocrinol. 2013;169:725–33